Iradimed share price logo

Iradimed

NASDAQ: IRMD

Small Cap

$85.06

-1.29

(-1.49%)

as on

Iradimed Stock Performance

as on September 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $84.60
    $87.20
    downward going graph

    0.54%

    Downside

    2.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $67.84
    $107.90
    downward going graph

    20.24%

    Downside

    26.85%

    Upside

    downward going graph

Iradimed share price movements today

Previous Close
$86.35
Open
$86.25
Volume
209.3K
Market Cap
$1.1B
Dividend Yield
1.47%
Day's Low - High
$84.60 - $87.20
52 Week Low - High
$67.84 - $107.90

Iradimed Historical Returns

1 Month Return
-0.95 %
3 Month Return
-8.78 %
1 Year Return
+ 22.95 %
3 Year Return
+ 98.69 %
5 Year Return
+ 152.56 %

Iradimed Stock Fundamentals & Key Indicators

Check Iradimed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

1.82

Dividend Yield

1.47%

Quarterly Earnings Growth YOY

-0.09%

PE Ratio (TTM)

47.53

Industry PE ratio

-6.13

PEG Ratio

4.077828224407164

EBITDA

31.1M

Revenue (TTM)

86.3M

Profit Margin

75.86%

Return On Equity TTM

23.45%

Iradimed Stock Valuation

Track how Iradimed P/E has moved over time to understand its valuation trends.

Iradimed in the last 5 years

  • Overview

  • Trends

Lowest (27.70x)

December 31, 2022

Industry (-6.13x)

December 31, 2025

Today (54.96x)

December 31, 2025

Highest (61.18x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 54.96x

Iradimed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iradimed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.1B152.56%47.5375.86%1.47%
Buy$51.2B-27.69%51.0277.98%0.00%
Buy$117.4B-31.32%22.1966.69%3.14%
StrongBuy$178.2B-16.79%33.3556.80%2.39%
StrongBuy$105.2B-1.17%28.2765.17%1.27%

Stock Returns calculator for Iradimed Stock including INR - Dollar returns

The Iradimed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Iradimed investment value today

Current value as on today

₹1,30,895

Returns

₹30,895

(+30.9%)

Returns from Iradimed Stock

₹21,116 (+21.12%)

Dollar Impact

₹9,779 (+9.78%)

Analyst Recommendation on Iradimed Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Iradimed. Average target price of $118

Iradimed Share Price Target

Get share price movements and forecasts by analysts on Iradimed.

What analysts predicted

27.92%UPSIDE

Target Price

$118

Current Price

$85.06

Analyzed by

1 Analysts

Target

$118.00

Iradimed target price $118, a slight upside of 27.92% compared to current price of $85.06. According to 1 analysts rating.

Indian Investors' Interest in Iradimed Stock

Search interest for Iradimed Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Iradimed Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
17
17
18
19
19
20
21
22
21
20
Gross Profit
13
14
14
14
14
15
16
17
16
15
Operating Income
4
5
5
5
5
6
6
7
7
6
EBITDA
5
6
6
6
6
7
7
8
8
6
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
5
6
6
6
5
7
7
7
7
6
Income Tax Expense
1
1
1
1
1
1
1
1
1
1
Net Income
4
4
5
5
4
5
5
6
5
5
Net Profit Margin
76.07%
78.14%
77.44%
76.13%
76.08%
78.17%
77.80%
75.06%
76.50%
74.07%

Iradimed Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23
30
38
31
41
53
65
73
83
Gross Profit
17
23
29
23
32
41
50
56
64
Operating Income
1
6
8
0
9
15
20
21
26
EBITDA
2
7
9
0
11
16
22
25
30
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
1
1
1
0
0
0
2
Income Before Tax
1
6
9
0
9
16
21
24
28
Income Tax Expense
0
0
0
-1
0
3
4
5
5
Net Income
0
6
9
1
9
12
17
19
22
Net Profit Margin
75.87%
76.31%
77.11%
74.33%
76.65%
77.45%
76.50%
76.94%
76.75%

Iradimed Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
4
4
5
5
4
5
5
6
5
5
Operating Cash Flow
3
6
9
5
4
7
6
5
8
5
Investing Cash Flow
0
-1
-4
-3
-3
-2
-1
0
0
0
Financing Cash Flow
-8
-1
-1
-2
-2
-2
-2
-10
-2
-2
Change in Cash
-4
3
3
0
-1
2
3
-5
5
2

Iradimed Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
6
9
1
9
12
17
19
22
Operating Cash Flow
3
7
10
5
11
10
13
25
24
Investing Cash Flow
-1
1
3
0
0
-1
-8
-8
-8
Financing Cash Flow
-1
0
2
0
0
-12
-13
-14
-17
Change in Cash
0
9
15
6
11
-4
-8
2
-1

Mutual Funds that own Iradimed Stock

Check out the Mutual Funds with significant holdings in Iradimed.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
2.737571%
350053
Virtus Equity Trust
1.102307%
140952
DFA INVESTMENT DIMENSIONS GROUP INC
0.887245%
113452
Fidelity Salem Street Trust
0.858106%
109726
TIAA-CREF Funds
0.826988%
105747

Global Institutional Holdings in Iradimed

Funds
Holdings
Vanguard
3.47%
iShares
3.04%
VANGUARD INDEX FUNDS
2.74%
Virtus Equity Trust
1.1%
DFA INVESTMENT DIMENSIONS GROUP INC
0.89%

Insights on Iradimed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IRMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IRMD stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IRMD has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 6.44M → 5.21M (in $), with an average decrease of 10.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 22.69M → 20.46M (in $), with an average decrease of 5.0% per quarter

About Iradimed

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
OrganisationIradimed
Headquarters1025 Willa Springs Drive, Orlando, FL, 32826, US
IndustryMedical - Devices
CEORoger E. Susi
E-voting on sharesClick here to vote

Key Management of Iradimed

Name

Title

Mr. Roger E. Susi

Founder, Chairman, CEO & President

Mr. John F. Glenn

CFO & Corporate Secretary

Mr. Jeff Chiprin

Chief Commercial Officer

Mr. Randy Waddell

Vice President of Worldwide Sales & Marketing

Mr. Chris Williamson

Executive Vice President of Continuous Improvement & Information Technology

Mr. Matt Garner

Controller

Mr. Lynn Neuhardt

Vice President of Research & Development

FAQs

What is Iradimed share price today?

Iradimed share price today is $85.06 as on at the close of the market. Iradimed share today touched a day high of $87.20 and a low of $84.60.

What is the 52 week high and 52 week low for Iradimed share?

Iradimed share touched a 52 week high of $107.90 on and a 52 week low of $67.84 on . Iradimed stock price today i.e. is closed at $85.06,which is 21.17% down from its 52 week high and 25.38% up from its 52 week low.

What is Iradimed's market capitalisation today?

Iradimed market capitalisation is $0.00T as on .

How to invest in Iradimed Stock (IRMD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Iradimed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iradimed Shares that will get you 0.0176 shares as per Iradimed share price of $85.06 per share as on September 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Iradimed Stock (IRMD) from India?

Indian investors can start investing in Iradimed (IRMD) shares with as little as ₹95.945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.45 in Iradimed stock (as per the Rupee-Dollar exchange rate as on ). Based on Iradimed share’s latest price of $85.06 as on September 25, 2026 at 1:29 am IST, you will get 0.1176 shares of Iradimed. Learn more about fractional shares .

What are the returns that Iradimed has given to Indian investors in the last 5 years?

Iradimed stock has given 152.56% share price returns and 29.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?